Crizotinib

Crizotinib is a kinase inhibitor indicated for the treatment of patients with-

  • Metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive
  • Metastatic NSCLC whose tumors are ROS1-positive

There are no products to list in this category.

Continue
Warning: Unknown: write failed: Disk quota exceeded (122) in Unknown on line 0Warning: Unknown: Failed to write session data (files). Please verify that the current setting of session.save_path is correct (/var/cpanel/php/sessions/ea-php56) in Unknown on line 0